Skip to main content
OpenTrials

Clinical trial condition

Primary Mediastinal Large B-cell Lymphoma (PMBCL)

Explore clinical trials studying Primary Mediastinal Large B-cell Lymphoma (PMBCL). Study availability and eligibility vary by location and protocol.

22 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Primary Mediastinal Large B-cell Lymphoma (PMBCL) trial results

Recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

NCT05934084

Conditions
Behavior, Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), +13 more
Locations
  • Ancona - AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
  • Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
  • Istituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare Bari, Italy
  • Ospedale S. Martino - UOC Oncologia Belluno, Italy
View all 40 locations
View Trial Details
Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

Bio-CAR-T BS Study

NCT05366569

Conditions
Acute Lymphoblastic Leukemia (ALL), Diffuse Large B Cell Lymphoma (DLBCL), Hematologic Diseases, +15 more
Locations
  • ASST Spedali Civili di Brescia Brescia, Italy
View Trial Details
Recruiting

SynKIR-310 for Relapsed/Refractory B-NHL

NCT06544265

Conditions
Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations
  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • The University of Kansas Cancer Center Fairway, Kansas, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View Trial Details
Recruiting

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

NCT06208735

Conditions
B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
View Trial Details

Related conditions